Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Foa

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|June 8, 2004
Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitroEnrica Orsini, Alessia Pasquale, Roberta Maggio, et al.
International Journal of Antimicrobial Agents|March 12, 2004
Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophilsGigliola Reato, Anna Maria Cuffini, Vivian Tullio, et al.
Haematologica|February 27, 2003
CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulationDaniela de Totero, P L Tazzari, Matteo Capaia, et al.
Haematologica|May 29, 2002
Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisoneFrancesca Romana Mauro, Massimo Gentile, Francesca Mancini, et al.
European Journal of Haematology|July 22, 2006
Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patientsGiuseppe Marotta, Antonio Frassoldati, Pierluigi Zinzani, et al.
Lancet (London, England)|June 9, 2004
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)Brunangelo Falini, Enrico Tiacci, Arcangelo Liso, et al.
British Journal of Haematology|September 15, 2005
Long-term follow-up of Philadelphia chromosome-positive (Ph) chronic myeloid leukaemia (CML) in children and adolescents managed at a single institution over a 20-year periodFiorina Giona, Maria Luisa Moleti, Ilaria Del Giudice, et al.
British Journal of Haematology|June 29, 2005
FLT3 inhibition in t(4;11)+ adult acute lymphoid leukaemiaGiovanni F Torelli, Anna Guarini, Alessandra Porzia, et al.
Cancer|December 22, 2004
Treatment of 72 newly diagnosed Waldenstrom macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone: results and cost analysisOmbretta Annibali, Maria Teresa Petrucci, Vincenza Martini, et al.
Leukemia & Lymphoma|April 25, 2007
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experienceMaria Luisa Moleti, Anna Maria Testi, Fiorina Giona, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|June 8, 2004
Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitroEnrica Orsini, Alessia Pasquale, Roberta Maggio, et al.
International Journal of Antimicrobial Agents|March 12, 2004
Immunomodulating effect of antimicrobial agents on cytokine production by human polymorphonuclear neutrophilsGigliola Reato, Anna Maria Cuffini, Vivian Tullio, et al.
Haematologica|February 27, 2003
CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulationDaniela de Totero, P L Tazzari, Matteo Capaia, et al.
Haematologica|May 29, 2002
Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisoneFrancesca Romana Mauro, Massimo Gentile, Francesca Mancini, et al.
European Journal of Haematology|July 22, 2006
Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patientsGiuseppe Marotta, Antonio Frassoldati, Pierluigi Zinzani, et al.
Lancet (London, England)|June 9, 2004
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)Brunangelo Falini, Enrico Tiacci, Arcangelo Liso, et al.
British Journal of Haematology|September 15, 2005
Long-term follow-up of Philadelphia chromosome-positive (Ph) chronic myeloid leukaemia (CML) in children and adolescents managed at a single institution over a 20-year periodFiorina Giona, Maria Luisa Moleti, Ilaria Del Giudice, et al.
British Journal of Haematology|June 29, 2005
FLT3 inhibition in t(4;11)+ adult acute lymphoid leukaemiaGiovanni F Torelli, Anna Guarini, Alessandra Porzia, et al.
Cancer|December 22, 2004
Treatment of 72 newly diagnosed Waldenstrom macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone: results and cost analysisOmbretta Annibali, Maria Teresa Petrucci, Vincenza Martini, et al.
Leukemia & Lymphoma|April 25, 2007
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experienceMaria Luisa Moleti, Anna Maria Testi, Fiorina Giona, et al.
Pageof 5